Literature DB >> 2086522

Prevalence and course of depressive disorders in hospitalized stroke patients.

P L Morris1, R G Robinson, B Raphael.   

Abstract

In a sample of ninety-nine patients seen two months post-stroke, 18 percent were diagnosed as having minor depression and 14 percent major depression. At follow-up, fifteen months later, the prevalence of depressive disorder had declined substantially, to 12 percent overall. Major depression was characterized by an average duration of thirty-nine weeks, a mortality rate of 23 percent and was associated with positive family history of affective or anxiety disorder. Among patients with left hemisphere lesions, major depression was associated with cognitive impairment. Minor depression had a shorter average duration (twelve weeks) and was more common in males. These two syndromes may define distinct types of post-stroke depression with implications for treatment interventions.

Entities:  

Mesh:

Year:  1990        PMID: 2086522     DOI: 10.2190/N8VU-6LWU-FLJN-XQKV

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  27 in total

Review 1.  A review of health-related quality-of-life measures in stroke.

Authors:  B A Golomb; B G Vickrey; R D Hays
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Correlations between Pre-morbid Personality and Depression Scales in Stroke Patients.

Authors:  Sung Il Hwang; Kyung In Choi; Oak Tae Park; Si-Woon Park; Eun Seok Choi; Sook-Hee Yi
Journal:  Ann Rehabil Med       Date:  2011-06-30

Review 3.  Poststroke depression: a review.

Authors:  Robert G Robinson; Gianfranco Spalletta
Journal:  Can J Psychiatry       Date:  2010-06       Impact factor: 4.356

4.  Pair housing reverses post-stroke depressive behavior in mice.

Authors:  Rajkumar Verma; Brett D Friedler; Nia M Harris; Louise D McCullough
Journal:  Behav Brain Res       Date:  2014-05-02       Impact factor: 3.332

5.  Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.

Authors:  H Palomäki; M Kaste; A Berg; R Lönnqvist; J Lönnqvist; M Lehtihalmes; J Hares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

6.  A one-year follow-up study into the course of depression after stroke.

Authors:  A Bour; S Rasquin; I Aben; A Boreas; M Limburg; F Verhey
Journal:  J Nutr Health Aging       Date:  2010-06       Impact factor: 4.075

7.  Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus.

Authors:  Yaozhi Hu; Haiyan Xing; Xiaomeng Dong; Wenxian Lu; Xinxing Xiao; Lilin Gao; Minghu Cui; Jinbo Chen
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

Review 8.  Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.

Authors:  Alastair J Flint
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

9.  Depressive disorders in stroke patients.

Authors:  E I Gusev; A N Bogolepova
Journal:  Neurosci Behav Physiol       Date:  2009-09

Review 10.  A model for intervention research in late-life depression.

Authors:  George S Alexopoulos; Martha L Bruce
Journal:  Int J Geriatr Psychiatry       Date:  2009-12       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.